Compare Mutual Funds
Pros | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | 5Y returns in the top 25% of the category. 3Y returns in the top 25% of the category. Among most bought funds within the category. | ||
Cons | 3Y returns in the bottom 25% of the category. | - |
INDMoney rank | 6/8 | 2/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 13 Years 5 Months | 7 Years 10 Months | ||
Fund AUM | ₹8306 Cr | ₹6801 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 0.91% | 1.04% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 39 | 43 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 1 | 2 | ||
Top 3 Sectors | Health (100%) |
| ||
Equity % | 99.7% | 97.98% | ||
Debt % | - | - | ||
P/E | 35.73 | 32.15 | ||
P/B | 5.7 | 3.94 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -4.77% | -3.26% | ||
3-Month Return | -6.09% | -8.72% | ||
6-Month Return | -3.31% | -7.04% | ||
1-Year Return | 4.6% | 4.74% | ||
3-Year Return | 22.01% | 25.65% | ||
5-Year Return | 14.54% | 16.72% |
Sharpe | 1 | 1.13 | ||
Alpha | -0.11 | 2.05 | ||
Beta | 0.91 | 0.95 | ||
Standard Deviation | 15.72 | 16.39 | ||
Information Ratio | -0.48 | 0.42 |
Description | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Sailesh Raj Bhan, Kinjal Desai, Amber Singhania | Dharmesh Kakkad, Sharmila D’mello |

